Categories AlphaGraphs, Earnings, Health Care
Johnson & Johnson (JNJ) Q2 2024 Earnings: Key financials and quarterly highlights
Johnson & Johnson (NYSE: JNJ) reported its second quarter 2024 earnings results today.
Reported sales increased 4.3% year-over-year to $22.4 billion. Operational sales growth was 6.6%.
Net income decreased 12.8% to $4.6 billion while EPS dropped 5.9% to $1.93. Adjusted EPS rose 10.2% to $2.82.
Revenue and earnings beat estimates.
For the full year of 2024, JNJ expects reported sales of $88.0-88.4 billion and adjusted EPS of $9.97-10.07.
The stock was down over 1% in premarket hours on Wednesday.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Broadcom (AVGO) reports higher Q3 revenue and profit; results beat estimates
Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) reported higher revenues and adjusted earnings for the third quarter of 2024 amid continued strong demand. The Q3 numbers also topped expectations. Earnings, excluding
Key takeaways from Hewlett Packard’s (HPE) Q3 2024 earnings report
Hewlett Packard Enterprise (NYSE: HPE) has delivered stronger-than-expected third-quarter results amid significant conversion in AI system revenues. The prospects for the company's AI server and edge computing businesses look promising
Hormel Foods (HRL): Factors that put a damper on the food company’s Q3 performance
Shares of Hormel Foods Corporation (NYSE: HRL) were up over 2% on Thursday. The stock is recovering from a fall it took a day ago after the company delivered mixed
